A slew of retail company earnings reports last week raised the spectre of sapped spending as executives discussed tariffs.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
Tesla’s stock closed down for a record seventh consecutive week on Friday, and has nearly erased a $700 billion post-election rally.
The Lone Star state has emerged, by a long shot, as the nation’s leader in renewable energy generation, according to new data.
Microgrids could offer a stopgap solution until small modular reactors are ready for the market.
Novo Nordisk will sell its blockbuster weight-loss drug Wegovy for under half its normal price via a new direct-to-consumer online pharmacy.
Policies floated by European Union leaders that could boost the bloc’s defense spending have sent the company’s shares flying.
Prada reported retail sales across its brands rose 18% last year as the company reportedly gears up to buy Versace from Capri Holdings.
The titanic port deal immediately made political waves, even as the seller, conglomerate CK Hutchison, denied politics were at play.
Here’s the bad news: Auto manufacturing is a notoriously thin-margin industry, and tariffs could tear right through those margins.
The biggest restaurant chain in the world just completed a splashy IPO — and you’ve likely never heard of it.
Eli Lilly last week announced a $27 billion investment in four different domestic manufacturing plants to boost weight-loss drug production.
As US-based streaming platforms chase audiences around the world, they’re increasingly committing to international productions.
On Wednesday, Bloomberg reported that one billion people are watching podcasts on the Google-owned YouTube every month.
European leaders are gearing up for the possibility of a sudden America-shaped hole in the Ukraine defense budget.
Now that semaglutide’s no longer in shortage territory, the FDA said drug-makers have 90 days to wrap up production of their Novo knockoffs.
Last Tuesday, content conglomerate Thomson Reuters notched a big legal win against AI firm ROSS. Is it a sign of what’s to come?